Abstract
This chapter examines the clinical and laboratory presentations of hypercalcemia and describes the clinical and laboratory findings that define an emergency situation in elevated serum calcium concentration. The initial approach to emergency treatment of hypercalcemia is presented. The differential diagnosis of hypercalcemia is tabulated, and the importance of distinguishing between the various diagnostic possibilities and its impact on the ongoing management of the condition is emphasized. The pathophysiology of the most common causes of hypercalcemia is explored in detail.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bushinsky DA, Krieger NS. Integration of calcium metabolism in the adult. In: Coe FL, Favus MJ, editors. Disorders of bone and mineral metabolism. New York: Raven; 1992. p. 417–32.
Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, Melton LJ III. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2006;21(1):171–7.
Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94(2):351–65.
Broome JT, Solorzano CC. Lithium use and primary hyperparathyroidism. Endocr Pract. 2011;17(Suppl 1):31–5.
Brown EM. Clinical lessons from the calcium-sensing receptor. Nat Clin Pract Endocrinol Metab. 2007;3(2):122–33.
Mallette LE, Eichhorn E. Effects of lithium carbonate on human calcium metabolism. Arch Intern Med. 1986;146(4):770–6.
Adami S, Rossini M. Hypercalcemia of malignancy: pathophysiology and treatment. Bone. 1992;13(Suppl 1):S51–5.
Clines GA. Mechanisms and treatment of hypercalcemia of malignancy. Curr Opin Endocrinol Diabetes Obes. 2011;18(6):339–46.
Mundy GR, Guise TA. Hypercalcemia of malignancy. Am J Med. 1997;103(2):134–45.
Ralston SH. Pathogenesis and management of cancer associated hypercalcaemia. Cancer Surv. 1994;21:179–96.
Strewler GJ. The physiology of parathyroid hormone-related protein. N Engl J Med. 2000;342(3):177–85.
Clines GA, Guise TA. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. Endocr Relat Cancer. 2005;12(3):549–83.
Hewison M, Kantorovich V, Liker HR, Van Herle AJ, Cohan P, Zehnder D, Adams JS. Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J Bone Miner Res. 2003;18(3):579–82.
Iguchi H, Miyagi C, Tomita K, Kawauchi S, Nozuka Y, Tsuneyoshi M, Wakasugi H. Hypercalcemia caused by ectopic production of parathyroid hormone in a patient with papillary adenocarcinoma of the thyroid gland. J Clin Endocrinol Metab. 1998;83(8):2653–7.
Mahoney EJ, Monchik JM, Donatini G, De Lellis R. Life-threatening hypercalcemia from a hepatocellular carcinoma secreting intact parathyroid hormone: localization by sestamibi single-photon emission computed tomographic imaging. Endocr Pract. 2006;12(3):302–6.
Nielsen PK, Rasmussen AK, Feldt-Rasmussen U, Brandt M, Christensen L, Olgaard K. Ectopic production of intact parathyroid hormone by a squamous cell lung carcinoma in vivo and in vitro. J Clin Endocrinol Metab. 1996;81(10):3793–6.
Sharma OP. Hypercalcemia in granulomatous disorders: a clinical review. Curr Opin Pulm Med. 2000;6(5):442–7.
Alikhan Z, Singh A. Hyperthyroidism manifested as hypercalcemia. South Med J. 1996;89(10):997–8.
Ghaferi AA, Chojnacki KA, Long WD, Cameron JL, Yeo CJ. Pancreatic VIPomas: subject review and one institutional experience. J Gastrointest Surg. 2008;12(2):382–93.
Stewart AF, Hoecker JL, Mallette LE, Segre GV, Amatruda TT Jr, Vignery A. Hypercalcemia in pheochromocytoma. Evidence for a novel mechanism. Ann Intern Med. 1985;102(6):776–9.
Stewart AF, Adler M, Byers CM, Segre GV, Broadus AE. Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med. 1982;306(19):1136–40.
Buckley MS, Leblanc JM, Cawley MJ. Electrolyte disturbances associated with commonly prescribed medications in the intensive care unit. Crit Care Med. 2010;38(6 Suppl):S253–64.
Desai HV, Gandhi K, Sharma M, Jennine M, Singh P, Brogan M. Thiazide-induced severe hypercalcemia: a case report and review of literature. Am J Ther. 2010;17(6):e234–6.
Orwoll ES. The milk-alkali syndrome: current concepts. Ann Intern Med. 1982;97(2):242–8.
Bhalla K, Ennis DM, Ennis ED. Hypercalcemia caused by iatrogenic hypervitaminosis a. J Am Diet Assoc. 2005;105(1):119–21.
Bilezikian JP. Clinical review 51: management of hypercalcemia. J Clin Endocrinol Metab. 1993;77(6):1445–9.
Nielsen S, Frokiaer J, Marples D, Kwon TH, Agre P, Knepper MA. Aquaporins in the kidney: from molecules to medicine. Physiol Rev. 2002;82(1):205–44.
Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, Udesky J, Silverberg SJ. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab. 2008;93(9):3462–70.
Jacobs TP, Bilezikian JP. Clinical review: rare causes of hypercalcemia. J Clin Endocrinol Metab. 2005;90(11):6316–22.
Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY, Keutmann HT, Wang CA, Potts JT Jr, Segre GV. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 1987;33(8):1364–7.
Nilsson IL, Zedenius J, Yin L, Ekbom A. The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy. Endocr Relat Cancer. 2007;14(1):135–40.
Casez J, Pfammatter R, Nguyen Q, Lippuner K, Jaeger P. Diagnostic approach to hypercalcemia: relevance of parathyroid hormone and parathyroid hormone-related protein measurements. Eur J Intern Med. 2001;12(4):344–9.
LeGrand SB, Leskuski D, Zama I. Narrative review: furosemide for hypercalcemia: an unproven yet common practice. Ann Intern Med. 2008;149(4):259–63.
Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med. 2005;352(4):373–9.
Wang CC, Chen YC, Shiang JC, Lin SH, Chu P, Wu CC. Hypercalcemic crisis successfully treated with prompt calcium-free hemodialysis. Am J Emerg Med. 2009;27(9):1174.e1–3.
Drake MT, Clarke BL, Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc. 2008;83(9):1032–45.
Ljunghall S. Use of clodronate and calcitonin in hypercalcemia due to malignancy. Recent Results Cancer Res. 1989;116:40–5.
Hu MI, Glezerman IG, Leboulleux S. Denosumab for treatment of hypercalcemia of malignancy. J Clin Endocrinol Metab. 2014;99(9):3144–52.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Klein, R., Vanek, C. (2021). Hypercalcemia. In: Loriaux, L., Vanek, C. (eds) Endocrine Emergencies. Contemporary Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-030-67455-7_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-67455-7_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-67454-0
Online ISBN: 978-3-030-67455-7
eBook Packages: MedicineMedicine (R0)